Design of pH-independent extended release matrix tablets of minocycline hydrochloride for the treatment of dementia

Kwang Ho Cha, Junsung Park, Wonkyung Cho, Dong Geon Gu, Kihyang Jeong, Sung Joo Hwang

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The aim of this study was to develop a pH-independent extended release matrix tablet of minocycline HCl for the treatment of dementia. The matrix tablets were prepared by wet granulation technique using Eudragit L and S as release modifiers at different w/w ratios (1:0, 1:1 and 0:1) and PEO as a matrix former. In the case of the matrix tablet without any release modifiers, the drug release rate at pH 1.2 was much higher than that of pH 7.4. By adding the release modifier, the drug release rate at pH 7.4 increased close to that of pH 1.2 and the pH-independent release was obtained. In addition, it was shown that lubricants containing a divalent cation such as Mg stearate inhibited minocycline release in basic medium. Therefore, the incorporation of Eudragit L and S (1:1 ratio) as release modifiers and Na stearyl fumarate as a lubricant into PEO-based matrix tablets effectively produced pH-independent minocycline release profiles.

Original languageEnglish
Pages (from-to)1593-1598
Number of pages6
JournalArchives of pharmacal research
Volume32
Issue number11
DOIs
Publication statusPublished - 2009 Nov 1

Fingerprint

Minocycline
Tablets
Dementia
Lubricants
Stearates
Fumarates
Granulation
Divalent Cations
Polyethylene oxides
Pharmaceutical Preparations
methylmethacrylate-methacrylic acid copolymer

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Drug Discovery
  • Organic Chemistry

Cite this

Cha, Kwang Ho ; Park, Junsung ; Cho, Wonkyung ; Gu, Dong Geon ; Jeong, Kihyang ; Hwang, Sung Joo. / Design of pH-independent extended release matrix tablets of minocycline hydrochloride for the treatment of dementia. In: Archives of pharmacal research. 2009 ; Vol. 32, No. 11. pp. 1593-1598.
@article{6c329d88e5ba47d1b8afde8237f43d79,
title = "Design of pH-independent extended release matrix tablets of minocycline hydrochloride for the treatment of dementia",
abstract = "The aim of this study was to develop a pH-independent extended release matrix tablet of minocycline HCl for the treatment of dementia. The matrix tablets were prepared by wet granulation technique using Eudragit L and S as release modifiers at different w/w ratios (1:0, 1:1 and 0:1) and PEO as a matrix former. In the case of the matrix tablet without any release modifiers, the drug release rate at pH 1.2 was much higher than that of pH 7.4. By adding the release modifier, the drug release rate at pH 7.4 increased close to that of pH 1.2 and the pH-independent release was obtained. In addition, it was shown that lubricants containing a divalent cation such as Mg stearate inhibited minocycline release in basic medium. Therefore, the incorporation of Eudragit L and S (1:1 ratio) as release modifiers and Na stearyl fumarate as a lubricant into PEO-based matrix tablets effectively produced pH-independent minocycline release profiles.",
author = "Cha, {Kwang Ho} and Junsung Park and Wonkyung Cho and Gu, {Dong Geon} and Kihyang Jeong and Hwang, {Sung Joo}",
year = "2009",
month = "11",
day = "1",
doi = "10.1007/s12272-009-2112-2",
language = "English",
volume = "32",
pages = "1593--1598",
journal = "Archives of Pharmacal Research",
issn = "0253-6269",
publisher = "Pharmaceutical Society of Korea",
number = "11",

}

Design of pH-independent extended release matrix tablets of minocycline hydrochloride for the treatment of dementia. / Cha, Kwang Ho; Park, Junsung; Cho, Wonkyung; Gu, Dong Geon; Jeong, Kihyang; Hwang, Sung Joo.

In: Archives of pharmacal research, Vol. 32, No. 11, 01.11.2009, p. 1593-1598.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Design of pH-independent extended release matrix tablets of minocycline hydrochloride for the treatment of dementia

AU - Cha, Kwang Ho

AU - Park, Junsung

AU - Cho, Wonkyung

AU - Gu, Dong Geon

AU - Jeong, Kihyang

AU - Hwang, Sung Joo

PY - 2009/11/1

Y1 - 2009/11/1

N2 - The aim of this study was to develop a pH-independent extended release matrix tablet of minocycline HCl for the treatment of dementia. The matrix tablets were prepared by wet granulation technique using Eudragit L and S as release modifiers at different w/w ratios (1:0, 1:1 and 0:1) and PEO as a matrix former. In the case of the matrix tablet without any release modifiers, the drug release rate at pH 1.2 was much higher than that of pH 7.4. By adding the release modifier, the drug release rate at pH 7.4 increased close to that of pH 1.2 and the pH-independent release was obtained. In addition, it was shown that lubricants containing a divalent cation such as Mg stearate inhibited minocycline release in basic medium. Therefore, the incorporation of Eudragit L and S (1:1 ratio) as release modifiers and Na stearyl fumarate as a lubricant into PEO-based matrix tablets effectively produced pH-independent minocycline release profiles.

AB - The aim of this study was to develop a pH-independent extended release matrix tablet of minocycline HCl for the treatment of dementia. The matrix tablets were prepared by wet granulation technique using Eudragit L and S as release modifiers at different w/w ratios (1:0, 1:1 and 0:1) and PEO as a matrix former. In the case of the matrix tablet without any release modifiers, the drug release rate at pH 1.2 was much higher than that of pH 7.4. By adding the release modifier, the drug release rate at pH 7.4 increased close to that of pH 1.2 and the pH-independent release was obtained. In addition, it was shown that lubricants containing a divalent cation such as Mg stearate inhibited minocycline release in basic medium. Therefore, the incorporation of Eudragit L and S (1:1 ratio) as release modifiers and Na stearyl fumarate as a lubricant into PEO-based matrix tablets effectively produced pH-independent minocycline release profiles.

UR - http://www.scopus.com/inward/record.url?scp=72049100389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72049100389&partnerID=8YFLogxK

U2 - 10.1007/s12272-009-2112-2

DO - 10.1007/s12272-009-2112-2

M3 - Article

C2 - 20091273

AN - SCOPUS:72049100389

VL - 32

SP - 1593

EP - 1598

JO - Archives of Pharmacal Research

JF - Archives of Pharmacal Research

SN - 0253-6269

IS - 11

ER -